Exploring decaprenyl-phosphoryl ribose epimerase (DprE1) as a validated target for TB drug discovery: Assay development, high-throughput screening and search for novel DprE1 inhibitor scaffolds

Informazioni relative al progetto

DPRETB

ID dell’accordo di sovvenzione: 252802

Progetto chiuso

Data di avvio 1 Maggio 2010

Data di completamento 30 Aprile 2012

Finanziato da

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 174 065,20

Contributo UE € 174 065,20

Coordinato da

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland